Accessibility Menu
OrthoPediatrics logo

OrthoPediatrics(NASDAQ) KIDS

Market Cap$518.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+5%
5 Year-68%
1 Year-3%
1 Month+5%
$20.21
+0.50%
+0.10Today
After hours$20.21+$0.00 (+0.00%)
OrthoPediatrics last closing stock price
MetricPriceDate
Last closeUSD 20.192026-07-31
OrthoPediatrics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7%USD 18.872026-07-24
1 month+4.61%USD 19.302026-07-01
3 month+29.17%USD 15.632026-05-01
Year to date+13.68%USD 17.762025-12-31
1 year-2.56%USD 20.722025-07-31
3 year-49.19%USD 39.742023-08-01
5 year-67.87%USD 62.842021-07-30
Since inception+5.05%USD 19.222017-10-12

OrthoPediatrics Financials at a Glance

Market Cap

$518.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$243.30M

Net Income (TTM)

-$39.68M

EPS (TTM)

-$1.68

P/E Ratio

-12.00

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$20.21

Volume

114,931.854

Open

$20.12

Previous Close

$20.19

Daily Range

$19.44 - $20.25

52-Week Range

$14.42 - $22.80

Estimated Earnings Date

Aug 4, 2026

KIDS News

Foolcom-Featured.png

OrthoPediatrics (KIDS) Q2 Revenue Up 16%

Motley Fool Markets TeamAug 5, 2025
GettyImages-1204177559

3 Stocks to Buy and Hold for the Long Term

Taylor CarmichaelAug 21, 2022

KIDS: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OrthoPediatrics

Orthopediatrics makes medical gear just for children. They help surgeons fix bone injuries and spine problems. These tools fit a child's growing body.

Helping Kids Heal

  • Trauma and Deformity: Implants and tools for fixing broken bones or physical defects; accounts for 73% of net revenue.
  • Scoliosis: Systems for treating curved spines in children; accounts for 26% of net revenue.
  • Sports Medicine: Procedures to treat soft tissue injuries in young athletes; accounts for 1.5% of net revenue.
  • Clinical Services: Custom bracing and artificial limbs provided through a network of over 50 pediatric clinics.

Growing the Global Network

  • Acquired London Orthotic Consultancy Consolidated Ltd on February 1, 2026, to expand its specialty bracing services in the UK.
  • Purchased several orthotic and prosthetic clinics through its Boston Brace International subsidiary during 2025.
  • Established Orthopediatrics do Brasil Ltda in November 2025 to sell and distribute products directly to the Brazilian market.
  • Secured $100 million in financing from Braidwell LP in August 2024 to fund operations and product development.

Standing Out in Healthcare

The company is the only global medical device firm focused exclusively on the pediatric orthopedic market. It uses a contract manufacturing model for surgical implants while producing most bracing products in-house.

By the Numbers

  • Net revenue reached $59.4 million in Q1 2026, up 13.3% year-over-year.
  • Operating loss narrowed to $8.3 million in Q1 2026, an improvement of 24.1% from the previous year.
  • Net loss reached $10.7 million in Q1 2026, a 0.3% decline that worsened from the prior year.
  • Free cash flow hit -$5.0 million in Q1 2026, narrowing and improving by 39.8% year-over-year.

Bottom Line

Orthopediatrics has evolved from a device maker into a provider of both surgical tools and specialized clinical care. By focusing only on children, the company has built a unique position in a market often ignored by larger firms.

AI Generated • May 6, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

602

CEO

David R. Bailey

Website

www.orthopediatrics.com

Headquarters

Warsaw, IN 46582, US

KIDS Financials

Key Financial Metrics (TTM)

Gross Margin

73.07%

Operating Margin

-12.07%

Net Income Margin

-16.31%

Return on Equity

-11.42%

Return on Capital

-6.49%

Return on Assets

-7.90%

Earnings Yield

-8.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$518.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

25.68M

Volume

114.93K

Avg. Volume

156.47K

Financials (TTM)

Gross Profit

$177.79M

Operating Income

-$29.36M

EBITDA

-$6.63M

Operating Cash Flow

-$3.98M

Capital Expenditure

-$8.64M

Free Cash Flow

-$12.63M

Cash & ST Invst.

$50.86M

Total Debt

$106.28M

OrthoPediatrics Performance Analysis

OrthoPediatrics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 122,289,00024.7%
20232023-12-31USD 148,732,00021.6%
20242024-12-31USD 204,727,00037.6%
20252025-12-31USD 236,348,00015.4%
OrthoPediatrics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3016.5%
Q32025-09-300.3%
Q42025-12-310.6%
Q12026-03-31-3.6%
OrthoPediatrics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.06N/A
20232023-12-31USD -0.93N/A
20242024-12-31USD -1.6477.2%
20252025-12-31USD -1.693.1%
OrthoPediatrics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3034.8%
Q32025-09-30-66.7%
Q42025-12-3114.0%
Q12026-03-31-4.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$59.36M

+13.3%

Gross Profit

$43.39M

+13.4%

Gross Margin

73.09%

N/A

Market Cap

$518.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$861.43K

N/A

Employees

602

N/A

Net Income

-$10.69M

-0.3%

EBITDA

-$3.04M

+29.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$50.86M

-13.5%

Total Debt

$106.28M

+45.2%

Accounts Receivable

$54.43M

+23.7%

Inventory

$134.02M

+11.9%

Long Term Debt

$103.35M

+41.5%

Short Term Debt

$2.93M

+1708.6%

Return on Assets

-7.90%

N/A

Return on Invested Capital

-6.45%

N/A

Free Cash Flow

-$5.05M

+39.8%

Operating Cash Flow

-$3.29M

+20.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TOIThe Oncology Institute, Inc.
$4.86-4.14%
SRDXSurmodics, Inc.
$42.98+0.35%
EOLSEvolus, Inc.
$5.84-2.83%
CBLLCeriBell, Inc.
$17.69+0.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About KIDS

What is the current price of OrthoPediatrics?

OrthoPediatrics is trading at $20.19 per share.

What is the 52-week range for OrthoPediatrics?

Over the past 52 weeks, OrthoPediatrics has traded between $14.42 and $22.80.

How much debt does OrthoPediatrics have?

As of the most recent reporting period, OrthoPediatrics reported total debt of $106.28M.

How much cash does OrthoPediatrics have on hand?

OrthoPediatrics reported $14.25M in cash and cash equivalents in its most recent financial results.

What is OrthoPediatrics’s dividend yield?

OrthoPediatrics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services